{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:40:20Z","timestamp":1782351620319,"version":"3.54.5"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1219,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1365-2230.2012.04357.x","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T16:16:11Z","timestamp":1335888971000},"page":"879-881","source":"Crossref","is-referenced-by-count":37,"title":["Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus"],"prefix":"10.1093","volume":"37","author":[{"given":"F.","family":"Worsnop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Natkunarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,4,30]]},"reference":[{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding","volume":"6","author":"French","year":"2006","journal-title":"Inter Immunopharm"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-\u03b1 antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/00015550510037062","article-title":"Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab","volume":"85","author":"Al-Shouli","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2340\/00015555-0462","article-title":"Eneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis","volume":"88","author":"Wojtkiewicz","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1346-8138.2010.00893.x","article-title":"Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab","volume":"37","author":"Kreft","year":"2010","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-\u03b1 treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2008.09.032","article-title":"Lichen planus-like eruptions. An emerging side effect of tumour necrosis factor-\u03b1 antagonsists","volume":"61","author":"Asarch","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB8|cit8","first-page":"188","article-title":"Lichen planus associated with etanercept","volume":"158","author":"Battistella","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/1153428-S0-000000000-00000","article-title":"Onset of lichen planus during treatment with etanercept","volume":"11","author":"Musumeci","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04357.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2012.04357.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2012.04357.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:25:37Z","timestamp":1713925537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/37\/8\/879\/6622785"}},"subtitle":["Infliximab for the treatment of TEN subsequently triggering erosive LP"],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04357.x","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4,30]]}}}